Andrea M. Baran

Andrea M. Baran, M.S. serves as a Senior Associate (Part-Time) in the Department of Biostatistics and Computational Biology at the University of Rochester School of Medicine and Dentistry. With expertise spanning biostatistics, oncology, and infectious diseases, she contributes significantly to clinical research across multiple medical disciplines through rigorous statistical analysis and methodological innovation.

Her educational background includes:

• MS in Medical Statistics from University of Rochester School of Medicine & Dentistry (2009)
• BS in Cell Biology, Cytology from University of Rochester (2008)
• BA in Statistics from University of Rochester (2008)

Ms. Baran's research focuses on biostatistical methodology applied to clinical medicine, with particular emphasis on oncology, hematology, and infectious disease applications. Her work bridges statistical theory with clinical practice, developing analytical approaches for complex medical data including gene expression patterns, clinical trial outcomes, and disease progression models. She has made significant contributions to studies examining miRNA analysis, clinical trial design, and biomarker development.

Analysis of her recent publication record reveals a strong concentration on hematologic malignancies, particularly chronic lymphocytic leukemia and lymphoma, where she applies sophisticated statistical models to evaluate treatment efficacy, resistance mechanisms, and patient outcomes. Her work also extends to infectious disease research, where she develops statistical approaches for understanding host immune responses to respiratory viruses and other pathogens.

While specific awards are not mentioned in available records, her extensive publication history in high-impact journals including Journal of Infectious Diseases, Blood Advances, and Genome Biology demonstrates significant recognition within her fields of expertise.

Ms. Baran collaborates extensively with clinical researchers across the University of Rochester Medical Center, providing biostatistical leadership for numerous clinical trials and observational studies. Her work supports research initiatives in oncology, hematology, infectious diseases, and geriatric care, contributing to evidence-based medical practice through rigorous statistical analysis and interpretation of complex datasets.

She is actively involved in multiple research teams studying hematologic malignancies, infectious diseases, and clinical trial methodology, where her biostatistical expertise helps shape research design, data collection protocols, and interpretation of findings for clinical application.